 |
INTRODUCTION |
Heterotrimeric GTP-binding proteins (G
proteins)1 initiate a
heterogeneous array of cellular functions. The time course of G protein
signaling is generally limited by intrinsic GTPase activity of the G
subunits and reassociation of the G

heterotrimer. A number of
accessory mechanisms capable of altering this time course have been
described over the past few years. Most recent is a family of
multifunctional proteins called regulators of G protein signaling (RGS)
proteins (1-4) that share a well conserved 120-amino acid "RGS
domain." This domain interacts directly with G
-GTP subunits (5)
and carries out a key function of RGS proteins to accelerate the
intrinsic GTPase activity of G
-GTP, thereby terminating signaling
through reassociation of the heterotrimer (3, 6). The
GTPase-accelerating (or GAP) activity has been demonstrated to alter
the time course of many G protein-dependent cellular
functions, including membrane trafficking (7, 8), lymphocyte chemotaxis
(9), hormone signaling (10, 11), rod photoreception (12, 13),
K+ channel activation (14, 15), and Ca2+
channel inhibition (16-19).
As observed with GAPs for monomeric G proteins (20, 21), some
specificity of interaction has been described between RGS proteins and
heterotrimeric G
subunits, but the specificity appears to be
surprisingly limited for many RGS proteins (22-25). Given that such
assays are often carried out on recombinant proteins in
vitro, it is possible that assay conditions give rise to
artifactually low specificity. As most RGS proteins contain additional
protein-protein interaction domains (e.g. cysteine string,
PTB, GGL, DEP, and PDZ motifs), such domains are likely determinants of
RGS-target interactions (19, 26, 27). Studies of RGS proteins in intact cells, particularly primary cells in which G
protein-dependent signaling pathways have been well
characterized, are likely to shed some light on this issue.
Sensory neurons from embryonic chick have proven to be a valuable model
of differentiated cells in which to test specificity of G
protein-dependent signaling (17, 28-30). Acting through metabotropic GABA type B receptors on these neurons, the
neurotransmitter GABA inhibits voltage-gated Ca2+ channels
through two distinct Go-mediated pathways. One pathway reduces Ca2+ current via Go
and a Src-like
tyrosine kinase (28, 31). A second pathway reduces current via a direct
interaction between Go
and the channel (28, 32).
These two pathways also exhibit distinct biophysical characteristics.
The Go
-mediated inhibition is
voltage-dependent (VD) and can be reversed at very positive voltages, whereas the G
/Src-mediated inhibition is
voltage-independent (VI) (28, 33).
Previous experiments carried out in the Dunlap laboratory (17) tested
human RGS-GAIP on these chick neurons through intracellular application
of the recombinant protein; it was found to terminate rapidly both
types of Go-mediated inhibition without affecting the
Gi-dependent form of Ca2+ channel
inhibition also present in the cells. This specificity for
Go was somewhat surprising in light of the significant GAP activity of human GAIP demonstrated in vitro against most
Gi
and Go
subunits tested (6, 34),
underscoring the potential importance of the cellular environment.
We have further explored this issue of GAIP specificity by using a
novel GAIP cDNA, cloned from a chick sensory neuron library. We
report here that chick GAIP has a short N terminus that is phylogenetically divergent from mammalian orthologues. By using in vitro GTPase assays with recombinant G
subunits and
electrophysiological recording of Go-mediated
Ca2+ channel inhibition, we demonstrate that chick GAIP is
more selective than its human counterpart both in vitro and
in intact cells. These results suggest that the unique N terminus of
chick GAIP confers functional specificity both in vitro and
in vivo.
 |
EXPERIMENTAL PROCEDURES |
Reverse Transcriptase-PCR--
Dorsal root ganglion neurons were
dissected from 11- or 12-day-old chicken embryos (Charles River SPAFAS,
North Franklin, CT) as described (35), and total RNA was extracted by a
phenol/guanidinium thiocyanate method (Tel-Test Inc., Friendswood, TX).
Freshly obtained RNA (0.5-1 µg) was used as template for reverse
transcription using Moloney murine leukemia-virus reverse transcriptase
(2.5 units/µl), 4 mM dNTP mix, and a 1:1 mix of random
hexamer and oligo(dT) (2.5 µM) as primer. The reaction
mixture was heated at 42 °C for 15 min for first strand synthesis.
After addition of 1 unit of Taq DNA polymerase and 1 µM each of degenerate sense (5'-GAG AAC ATG(T) C(T)TC
(A)TTC TGG-3') and antisense (5'-TAG(T) GAG TCC CG(T)G TGC AT-3')
primers, which target the highly conserved RGS domain of mammalian
GAIP, PCR was performed using the following cycling protocol: 94 °C
for 1 min (1 cycle), 94 °C for 30 s, 45 °C for 1 min,
72 °C for 1 min (40 cycles), and 72 °C for 5 min (1 cycle).
Reaction products of the expected size (240 bp) were subcloned into
pCR2.1 (Invitrogen), mapped by restriction digestion, and sequenced.
Three independent clones yielded identical partial fragments of the
chick GAIP RGS domain.
cDNA Library Screening--
An embryonic chick DRG cDNA
library (in
ZAP II vector) was constructed as described (36). In
each round of screening, about 1 million plaques were transferred to
Nytran membranes (Schleicher & Schuell) in duplicate. Phage DNA was
denatured (0.5 M NaOH, 1.5 M NaCl) and
neutralized (0.5 M Tris-HCl, 1.5 M NaCl, pH
8.0). A 240-bp cDNA probe, corresponding to the PCR-amplified
fragment of the chick GAIP RGS domain (see above), was labeled with
[
-32P]dCTP using a random priming kit (Amersham
Biosciences) and added to a hybridization solution of 50% deionized
formamide, 0.8 M NaCl, 20 mM PIPES, 0.5% SDS,
100 µg/ml denatured salmon sperm DNA. After hybridization overnight
at 42 °C, membranes were washed twice at 58 °C for 45 min in wash
buffer (0.1× SSC, 0.1% SDS). Double-positive plaques were isolated,
amplified, and subjected to a second round of screening. Individual
plaques positive after the second screening were subjected to in
vitro excision using the Exassist/SORL system (Stratagene, La
Jolla, CA). Each phage gave rise to a phagemid (pBluescript) containing
an individual cDNA clone. The presence of a cDNA insert in the
phagemid was confirmed by restriction digestion and sequence analysis.
Northern Blot Analysis--
Twelve-day-old chicken embryos were
dissected, and total RNA was extracted from several tissues as
described above. Poly(A)+ RNA samples were then obtained
with the poly(A)+ Tract mRNA Purification System
(Promega, Madison, WI). An agarose gel (0.7% agarose, 2.2 M formaldehyde, 20 mM MOPS, 8 mM
sodium acetate, 1 mM EDTA, pH 7.0) was loaded with
poly(A)+ RNA from each tissue (1.5 µg); following
electrophoresis, the RNA was transferred to a Nytran membrane
(Schleicher & Schuell) by alkaline transfer (8 mM NaOH, 3 M NaCl, 1.5 h). A 580-bp PCR product containing most
of the coding region and part of the 3'-UTR of chick GAIP was labeled
with [
-32P]dCTP by random priming (see above), and
107 dpm/ml of probe were added to the hybridization
solution (Northern MAX Prehyb/Hyb Buffer, Ambion, Austin, TX). The blot
was hybridized overnight at 42 °C and then washed twice
(45 min at 60 °C) in Northern MAX Wash Buffer (Ambion). After
drying, the membranes were analyzed by autoradiography.
Expression and Purification of Recombinant Chick GAIP--
A
His6 tag was attached by PCR to the C terminus of chick
GAIP; the resulting construct was directionally subcloned into pET11a (Novagen, Madison, WI), and the vector was used to transform
Escherichia coli BL21 (DE3) cells. A 10-ml overnight culture
from a single colony was used to inoculate 1 liter of LB medium with
ampicillin (100 µg/ml) at 37 °C.
Isopropyl-1-thio-
-D-galactopyranoside (0.5 mM) induction was performed at
A600 = 0.6-0.8, and cell cultures were
shaken for 4 h prior to harvest. Cells were then centrifuged, resuspended in buffer A (50 mM HEPES, pH 8, 20 mM
-mercaptoethanol, 100 mM NaCl, 0.1 mM phenylmethylsulfonyl fluoride), and lysed by addition of
lysozyme (0.2 mg/ml) and sonication. DNase I (5 µg/ml) was added to
reduce viscosity. The resulting lysate was centrifuged (12,000 × g for 30 min at 4 °C), and the supernatant fraction was
loaded onto a column containing 1 ml of nickel-nitrilotriacetic acid
affinity resin (Qiagen, Hilden, Germany) pre-equilibrated with buffer
A. The column was washed with 50 ml of buffer A + 50 mM
imidazole, and GAIP was eluted with 5 ml of buffer A + 250 mM imidazole. The eluted protein was dialyzed overnight
against 1 liter of buffer B (50 mM HEPES, 2 mM
dithiothreitol, pH 8), concentrated using a Centricon 10 column
(Millipore, Bedford, MA), and stored at
80 °C. GAIP protein
preparations were 80-90% pure as assessed by Coomassie Blue staining
of conventional SDS-PAGE gels.
Single-turnover GTPase Assay--
GTPase assays were performed
using an automated fast-superfusion system with subsecond resolution
(37). Bovine G
i1, G
i3, or
G
o (2 µl, 100 µg/ml, Calbiochem) were incubated with
2 µl of [
-32P]GTP (6000 Ci/mM, 10 Ci/liter) and 6 µl of Mg2+-free HDE buffer (50 mM HEPES, 5 mM EDTA, 2 mM
dithiothreitol, pH 8.0) for 30 min at 30 °C to allow equilibrium
binding. Samples were then stored on ice, and His6-tagged
recombinant chick GAIP (3 µM final concentration) was
added to half. The labeled G
subunits, with or without GAIP, were
retained on a 5-mm diameter HA/GFF/HA filter sandwich and placed in a
superfusion chamber accessed by three high speed, solenoid driven
valves. Each computer-operated valve controlled delivery of a separate
solution to the chamber, allowing very rapid solution exchange. The
minimal dead volume of the chamber and the relatively high solution
flow rate permitted a time resolution for GAIP activity of at least 60 ms. The samples were superfused either with HDE buffer, to calculate
background, or with HDE + 10 mM MgCl2 to
trigger hydrolysis. Superfusate fractions were collected every 0.1 s for a total time of 1.3 s. Scintillation mixture (Hydrofluor,
National Diagnostic, Manville, NJ) was added to each sample, and the
amount of [
-32P]Pi released by each sample
was determined by liquid scintillation counting. For all experiments,
samples were assayed in triplicate and averaged and expressed as a
percentage of total radioactivity added to each filter.
Preparation and Electrophysiological Recordings of Chick DRG
Neurons--
Embryonic chick DRG neurons were grown in culture as
described previously under conditions identical to those of
Diversé-Pierluissi et al. (17). Briefly, dorsal root
ganglia were dissected from 11- or 12-day-old chick embryos (Charles
River SPAFAS) and incubated for 30 min at 37 °C in
Ca2+-, Mg2+-free saline containing 0.1%
collagenase A (Roche Molecular Biochemicals). After washing away the
collagenase, the ganglia were resuspended in ~1 ml of culture medium
(Dulbecco's modified Eagle's medium, supplemented with 10%
heat-inactivated horse serum, 5% chicken embryo extract, 50 units/ml
penicillin, 50 mg/ml streptomycin, 1 mM glutamine and nerve
growth factor) and mechanically dissociated by trituration through a
small-bore, fire-polished Pasteur pipette. A small drop of the cell
suspension (~100 µl) was placed in the center of a 35-mm tissue
culture dish and incubated at 37 °C to allow the cells to attach to
the substrate. After ~1 h of incubation, the plated dishes were
filled with culture medium.
Four to 48 h after plating, cultured DRG neurons were employed for
electrophysiological recordings of Ca2+ currents using
standard tight seal, whole-cell methods (38). Cells were visualized on
the stage of an inverted microscope, and the cell culture medium was
replaced with (in mM) 133 NaCl, 1 CaCl2, 0.8 MgCl2, 25 HEPES, 12.5 NaOH, 5 glucose, 10 tetraethylammonium Cl, 6 × 10
4 tetrodotoxin,
10
2 bicuculline, pH 7.4. All reagents were from Sigma.
Recording pipettes were fabricated from microhematocrit tubing (Fisher) and filled with an internal recording solution containing (in mM) 150 CsCl, 5 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid, 5 MgATP, 10 HEPES, pH 7.4. Pipette resistances varied between 0.8 and 1.5 megohms when filled with recording solution. Currents were
recorded using a List Biologic (Campbell, CA) EPC-7 patch clamp
amplifier, filtered at 3 kHz, digitized at 10 kHz using an ITC16 A/D
interface (Instrutech Corp., Great Neck, NY), and stored on a Macintosh
G3 PowerPC running Pulse software (HEKA Electronik, Germany).
Capacitive transients and series resistances were compensated with the
EPC-7 circuitry, and the leak currents were subtracted with a standard
P/4 protocol. All recordings were performed at room temperature. Igor
software (Wavemetrics, Lake Oswego, OR) was employed for data analysis.
The two components of GABA-mediated inhibition of N-type calcium
channels were separated using voltage protocols described in our
previous work (17, 28). Briefly, Ca2+ currents were evoked
by a 20-ms test pulse to 0 mV in the presence or absence of GABA.
Currents were measured at the time that control currents peaked
(Tp) and at the end of the step
(Te), and modulated currents were normalized to
control and expressed as a percentage. The difference between control
and modulated current at Tp constitutes the total
GABA-induced inhibition. The difference between the current at
Tp and Te represents the VD
portion of the inhibition produced by GABA; for convenience, the
remaining current was taken as an estimate of voltage-independent
inhibition. Although the VI component is contaminated by a portion of
VD inhibition not effectively reversed during the test pulse, this
contamination is likely no greater than 10% (35).
Ca2+ currents were corrected for rundown by measuring
Ca2+ currents as a function of time in control cells in the
absence of neurotransmitter. Analysis was confined to data from cells
that exhibited a rundown of less than 1%/min.
Solutions and Drug Delivery--
Drug and recording solutions
were prepared from stock solutions immediately before the experiment;
they were delivered rapidly (<1 s) via a pressurized system of
multiple converging quartz tubes (140 µm internal diameter)
positioned in the vicinity of the cell of interest. For all
experiments, GABA was diluted into the extracellular solution at a
working concentration of 100 µM, although GAIP was
diluted into the patch pipette solution to a final concentration of 300 nM.
Statistics--
All results are expressed as means ± S.E.
Statistical differences were analyzed using either paired or unpaired
Student's t tests, as appropriate, and differences were
considered significant when p < 0.05.
 |
RESULTS |
Cloning of Chick GAIP--
RNA from chick DRG neurons was used as
template for reverse transcriptase-PCR with degenerate primers derived
from regions of the RGS domain that are highly conserved among RGS
proteins (39). Along with a number of other RGS sequences, we obtained three independently cloned PCR products that encoded a 240-bp cDNA
with 85% identity to human GAIP (6), suggesting that we had amplified
the RGS domain of chick GAIP. In order to obtain the full-length GAIP
sequence, an embryonic chick DRG cDNA library was screened using a
radioactive probe synthesized from the identified 240-bp PCR product.
Three positive clones were isolated from the screening and sequenced.
Two of them were cDNAs of identical length and contained the entire
coding sequence of the target gene (Fig. 1).

View larger version (87K):
[in this window]
[in a new window]
|
Fig. 1.
Sequence analysis of chick GAIP.
A, deduced nucleotide and amino acid sequences of the 5'-UTR
and coding sequence of chick GAIP (entire cDNA sequence in
GenBankTM, accession number AF502147). Cysteine-rich domain
designated by boldface, shaded residues; RGS
domain indicated in boldface, italicized, and
double-underlined residues. B, alignment of the predicted
amino acid sequences for chick GAIP (.GG), its mammalian
orthologues (.HS, human; .RN, rat;
.MM, mouse) and other members of the GAIP subfamily of RGS
proteins. Cysteine-rich region (stippled bar) and the RGS
domain (cross-hatched bar). Sequences were aligned using
ClustalX on a Macintosh G3 PowerPC. The chick GAIP 5'-UTR immediately
upstream of the initial methionine (arrowhead) was
translated to compare with the N termini of mammalian GAIPs. Residues
boxed and indicated with 22 aa are deleted in
chick GAIP but present in mammalian GAIPs. Residues boxed
and indicated with +5 aa represent a 5-amino acid
(aa) insertion in chick GAIP and are absent in mammalian
GAIPs. C, unrooted tree of GAIP family members, generated by
neighbor-joining distance methods from the alignment in B
using ClustalX. This tree provides an approximation to the actual
evolutionary tree, showing sequence relatedness as a function of branch
length, where the branch length is proportional to the amount of change
along that branch (sequence distance). Scale bar indicates a
5% change in amino acid sequence.
|
|
Chick GAIP cDNA consists of 2164 bp, with a putative translation
initiation codon at nucleotide 277 and a TAA stop codon at nucleotide
874. An in-frame stop codon occurring at nucleotide 175 and a
satisfactory Kozak consensus sequence at nucleotide 271 confirm the ATG
at bp 277 as the initiator methionine (40). The 3'-untranslated region
does not contain a typical polyadenylation signal, AATAAA, but ends
with an uninterrupted sequence of 13 adenosines. In addition, two
TTTTGT motifs are present in the 3'-untranslated region (not shown).
These motifs are commonly present in immediate early genes and are
thought to play a role in transcriptional activation (41, 42). The open
reading frame consists of 597 bp, predicting a 199-amino acid,
23,321-Da protein (Fig. 1A). In agreement with human GAIP,
the deduced primary sequence of chick GAIP contains a C-terminal RGS
domain (Fig. 1A, double underlined) and an
N-terminal cysteine-rich (CR) region (shaded). In addition,
chick GAIP contains several putative phosphorylation sites for casein
kinase II and one putative N-glycosylation site (not shown).
The coding sequence was 66% identical to human GAIP and >50%
identical to GzGAP and RGS17 (two more distant members of the GAIP
family), confirming that the chick clone is a GAIP orthologue (Table
I) (43). Whereas human and rat GAIPs have a similar evolutionary profile, chick GAIP branches off from a common
precursor at an earlier point, reflecting a higher number of
evolutionary changes in its primary structure (Fig. 1C).
View this table:
[in this window]
[in a new window]
|
Table I
Identity/similarity matrix for GAIP family members
Percentages of sequence identity (gray background) and similarity
(white background) within the GAIP gene family calculated over
full-length
sequences.
|
|
The homology between chick and mammalian GAIPs is limited to the
residues in the RGS and CR domains. The initial portion of the N
terminus, from the initiator methionine to the beginning of the CR
domain, is particularly divergent from mammalian GAIPs (Fig.
1B). The methionine at position 1 of human GAIP is a
threonine (indicated with a black diamond) in chick GAIP,
moving the start site of chick GAIP 66 nucleotides downstream. In
addition, chick GAIP contains a 15-bp insertion not present in
mammalian GAIPs immediately 5' to the CR domain. Because the N terminus
has been shown to play an important role in the localization and
biological activity of some RGS proteins (44-47), the cloning results
suggested that chick GAIP may have unique functional properties. The C
terminus of chick GAIP also exhibits a few modifications, including a
single residue deletion immediately following the RGS domain. Taken
together, these changes give rise to a predicted chick protein that is
18 amino acids shorter than its human counterpart (Fig.
1A).
Tissue Distribution of Chick GAIP mRNA--
The distribution
of chick GAIP mRNA was investigated by probing a chick
poly(A)+ Northern blot with a 480-bp cDNA fragment
containing the coding region and part of the 5'-UTR of chick GAIP. As
shown in Fig. 2 (upper panel),
bands of comparable intensity corresponding to a transcript of 2.2 kb
can be detected in all tissues tested as follows: DRG neurons, brain,
lungs, liver, heart, skeletal muscle, and kidney. The length of the
transcript is consistent with the length of the cloned chick GAIP
cDNA. Interestingly, a second transcript of 1.5 kb, showing the
same expression pattern as the 2.2-kb transcript but a much stronger
signal, is also detected by the same probe. Neither band is present
when the blot is stripped and re-hybridized with a probe to human
glyceraldehyde-3-phosphate dehydrogenase, a gene commonly expressed in
all tissues and used as a control for mRNA loading (Fig. 2,
lower panel).

View larger version (93K):
[in this window]
[in a new window]
|
Fig. 2.
Northern blot analysis of chick GAIP
mRNA. Northern blot of mRNA purified from various tissues
(from 12 day-old chick embryos), blotted with 32P-labeled
probe specific for chick GAIP (upper panel) or human
glyceraldehyde-3-phosphate dehydrogenase (GPDH) (lower
panel, same blot stripped and reprobed as a control for loading).
Size markers at left are in kilobases. Arrows at
right indicate sizes of the two identified GAIP transcripts
(upper) or glyceraldehyde-3-phosphate dehydrogenase
(lower). DRG, dorsal root ganglia; B,
brain; H, heart; Lu, lung; Li, liver;
SM, skeletal muscle; K, kidney.
|
|
In Vitro GTPase Activity of Chick GAIP--
The best described
property of RGS proteins is their ability to act as GAPs for
heterotrimeric G
subunits. To test whether chick GAIP exhibited GAP
activity and to explore the extent of its specificity against
Gi/o
subunits in vitro, we employed a novel
biochemical assay that allows subsecond resolution of the time course
of intrinsic GTP hydrolysis of G
and its acceleration by GAIP.
Pre-formed complexes between purified, recombinant chick GAIP and
bovine [
-32P]GTP-bound G
subunits were immobilized
on glass fiber filters and rapidly superfused with a
Mg2+-containing solution to initiate GTP hydrolysis (and
the release of 32Pi into the superfusate).
Eluted fractions were collected every 0.1 s, and their
32Pi content was measured with liquid
scintillation spectroscopy. As shown in Fig.
3, chick GAIP effectively increased the
GTPase activity of all G
subunits tested (G
i1,
G
i3, and G
o), although the rate and
extent of the stimulation differed among the three G
subtypes.
Surprisingly, the strongest GAP activity was observed for
G
i1 and not G
i3 as has been reported for
human GAIP (6, 23). Chick GAIP stimulated an average 5.2 ± 1.3-fold increase in the rate of G
i1 GTPase activity,
producing a maximal stimulation of 12.3 ± 0.4-fold
(n = 4, Fig. 3D). In contrast, the GTPase
rates of G
i3 and G
o were augmented only
3.0 ± 0.5- and 1.3 ± 0.4-fold, respectively, producing
maximal fold increases of 4.6 ± 1.7 (n = 8) and
1.7 ± 0.2 (n = 4) (Fig. 3, B and
D). These data indicate that chick GAIP is a GAP for members
of the G
i/o family (similar to mammalian GAIP), but in
contrast to the latter, chick GAIP is most effective on
G
i1.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 3.
Chick GAIP is a GAP in
vitro. The ability of chick GAIP to accelerate the
intrinsic GTPase activity of several G subunits was tested in
vitro using an assay that allowed subsecond resolution of
GAIP-induced GTPase activity. G i1 (A),
G i3 (B), and G o (C)
subunits were loaded with [32P]GTP, and Pi
released into the superfusate was measured in the absence (open
symbols) or presence (filled symbols) of 3 µM chick GAIP. D, fold changes in
Pi release as a function of time calculated by subtracting
background counts and expressing as percentage of total radioactivity
loaded onto the filters. All points are means ± S.E. of numbers
of measurements noted in the text (from three separate
experiments).
|
|
Effects of Chick GAIP on Ca2+ Channel
Gating--
Prior to testing the actions of chick GAIP on G
protein-dependent modulation of Ca2+ current,
we investigated whether chick GAIP modified channel properties under
basal conditions. Macroscopic N currents were recorded over the course
of 10-15 min after achieving whole cell access. Pipettes contained
either control internal solution or internal solution with 300 nM recombinant chick GAIP. Under the two conditions, there
were no significant differences in the current-voltage relationships
(Fig. 4A, n = 4), current activation kinetics (Fig. 4B, n = 4), or the conductance-voltage curve (Fig. 4C,
n = 4), the latter an indirect measure of the channel
open probability. These results indicate that, as for other RGS
proteins (16, 17), chick GAIP does not directly modify the gating of
N-type Ca2+ channels.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 4.
Chick GAIP does not modify the gating
properties of N currents in chick DRG neurons. The current-voltage
relationship (A), the rate of current activation
(B), and the voltage dependence of activation (C)
of control N current (open symbols) or N current in the
presence of 300 nM chick GAIP (filled symbols).
G/Gmax (C) represents the normalized macroscopic
conductance and is a measure of the opening probability of the channel.
Data are means ± S.E. of measurements from four cells.
|
|
Chick GAIP Selectively Attenuates VI Inhibition of Ca2+
Current by GABA--
In chick DRG neurons, GABA typically inhibits
Ca2+ current in more than 80% of freshly dissociated DRG
neurons (48). Ca2+ currents were measured with 20-ms test
pulses to 0 mV, and 100 µM GABA was applied twice,
30 s after break-in (prior to significant GAIP diffusion) and 10+
min after break-in (sufficient time for equilibration of GAIP with the
cell interior) (Fig. 5A). This approach allows (i) GABA-resistant cells to be eliminated from the
analysis (<20% of cells tested), and (ii) each cell to be used as its
own internal control.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 5.
Chick GAIP reduces GABA-mediated inhibition
of N current. A, superimposed Ca2+ currents
evoked by 20-ms test pulses to 0 mV, recorded before (CON.),
during (GABA), or after (WASH) application of 100 µM GABA; recordings made within 30 s or after 15 min
of intracellular access, as marked. B, GABA-induced
inhibition measured after 30 s (triangles) or 15 min
(squares) of whole-cell access and plotted as a function of
time for voltage-independent inhibition (left) and
voltage-dependent inhibition (right).
Calibration bars: 500 pA, 5 ms. C, total
GABA-induced inhibition of N currents evoked by test pulses to 0 mV,
with recording pipettes containing control internal solution
(white bars) and or internal solution with 300 nM chick GAIP (gray bars). Inhibition was
measured early (after 30 s) and late (after 10+
min) following whole-cell access. The voltage-independent
(B) and voltage-dependent (C)
components of GABA-mediated inhibition at 0 mV were isolated as
described, and the effects of chick GAIP on each component was
separately assessed and plotted as in A. Double
asterisks indicate statistical significance with p < 0.01 (Student's two-tailed t test).
|
|
GABA inhibited Ca2+ currents to a similar extent in
GAIP-perfused (38.7 ± 7.9%, n = 5) and control
(35.0 ± 5.9%, n = 10) cells when measured
30 s after break-in. In contrast, after 10 min of cell dialysis,
GABA-induced inhibition in GAIP-perfused cells was only 22% that
measured initially in the same cells. However, the second application
of GABA produced a reduced inhibition also in control cells (71% of
the initial application, n = 10). This GAIP-independent
decrease in inhibition in control cells was likely due to
dialysis-induced changes of intracellular components essential for the
inhibition. Comparing GAIP-treated with control cells at the 10-min
time point demonstrated that GAIP significantly (p < 0.01) reduced GABA-mediated inhibition (8.6 ± 1.9% for
GAIP-treated versus 25.0 ± 4.8% for control) (Fig.
5C). These results indicate that chick GAIP is able to
couple to and regulate the activity of the GABA type B
receptor/G
o pathway(s) in DRG neurons.
Because GABA inhibits chick DRG Ca2+ channels via two
Go-coupled pathways, we explored whether chick GAIP
exhibits any selectivity among the two. The two forms of inhibition (VD
and VI) were separated with a 20-ms voltage pulse to 0 mV (see
"Experimental Procedures"). Currents were measured at the time that
control currents peaked (Tp) and at the end of the
step (Te), and modulated currents were normalized to
control and expressed as a percentage. The difference between control
and modulated current at Tp constitutes the total
GABA-induced inhibition (Fig. 5C). The difference between
the current at Tp and Te
represents the VD portion of the inhibition produced by GABA (Fig.
5E); the remaining current is an estimate of
voltage-independent inhibition (Fig. 5D). The inhibition was
approximately two-thirds VI and one-third VD (Fig. 5,
B, D, and E), consistent with results
obtained using a more precise 3-pulse voltage protocol (28, 33).
By comparing GAIP-treated cells to control cells, we found that GAIP
selectively reduced VI inhibition (Fig. 5D), leaving VD
inhibition unaffected (Fig. 5E). After 10 min of GAIP
application, GABA produced only a 5.6 ± 2.1% (n = 5) VI inhibition as compared with the 19.9 ± 4.0% observed in
control cells (n = 5). VD inhibition remained the same,
3.4 ± 1.4% for GAIP-treated versus 5.2 ± 1.1% for control (p > 0.1).
Chick GAIP Accelerates the Rates of Onset of and Recovery from
GABA-mediated Inhibition--
If the attenuation of GABA-mediated
inhibition observed for GAIP-treated cells is due to an acceleration of
the intrinsic GTPase activity of G
o, then changes in
rates of onset and recovery from GABA-induced inhibition would be
expected. As predicted by mass action, both forward and reverse rates
will depend upon the size of the heterotrimer pool (49). To test this,
a 20-ms voltage step to 0 mV was applied at 0.5 Hz before, during, and
after superfusion of the cell with 100 µM GABA. GABA
application rapidly inhibited Ca2+ current (Fig.
6A) with a time course well
described by a single exponential and a mean rate of 0.4 ± 0.06 s
1 (n = 10). GAIP produced a 75%
increase in the rate of GABA-induced inhibition (0.7 ± 0.07 s
1, n = 5). Once GABA-mediated inhibition
reached steady state, the superfusate was switched back to control
solution in order to measure recovery from inhibition. The time course
for recovery was also well described by a single exponential (Fig.
6B), with an average rate of 0.25 ± 0.03 s
1 in control cells (n = 5). This rate
was 136% faster in GAIP-treated cells (0.59 ± 0.02 s
1, n = 10).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 6.
Chick GAIP accelerates the onset and recovery
from GABA-induced inhibition. The rates of GABA-induced inhibition
of N current (A) and recovery from GABA-induced inhibition
(B) were measured in control cells (white bars)
and in cells exposed to 300 nM GAIP (gray bars)
soon after whole-cell access was achieved (after 30 s) and
at least 10 min later (after 10+ min). The values for total
inhibition as well as the voltage-independent and
voltage-dependent inhibition are plotted separately, as
marked. Data represent means ± S.E. of four independent
measurements. Asterisks indicate statistical significance
with p < 0.05 (Student's two-tailed t
test).
|
|
As expected from the results above, when GABA-induced inhibition was
resolved into its two components, chick GAIP was found to accelerate
selectively the onset and recovery of VI inhibition, with the time
course of VD inhibition remaining unchanged (Fig. 6). These results
confirm that chick GAIP acts as a selective GAP for the Go
pathway underlying VI inhibition.
 |
DISCUSSION |
Chick GAIP Is a Unique Isoform--
We have cloned and
characterized a 2164-bp cDNA encoding the full-length sequence of
chick GAIP. Chick GAIP is expressed as a 2.2-kb transcript, as
determined by Northern hybridization and is detected in all tissues
tested, with the highest levels in brain and the lowest in liver,
skeletal muscle, and kidney. A second transcript, 1.5 kb in size, was
detected by the GAIP probe. This transcript shows the same tissue
expression pattern as the 2.2 transcript but is more abundant. Because
both bands were consistently observed under high stringency
hybridization conditions, in distinct blots, and with different
GAIP-specific probes, it is not likely that they are
cross-hybridization artifacts. We believe they are more likely to
represent two independent GAIP mRNAs. This conclusion is supported
by the fact that the two transcripts have the same expression pattern,
more abundant in brain, weaker in liver, kidney, and skeletal muscle,
although a control gene, glyceraldehyde-3-phosphate dehydrogenase,
exhibits a completely different tissue distribution. Furthermore, the
length of the 1.5-kb transcript is consistent with that reported for
human GAIP (6, 50). The difference between the 2.2- and 1.5-kb
transcripts is mostly likely to reside in the length of the 3'-UTR; the
probe used in the Northern blot hybridizes to 498 of the 597 nucleotides in the coding region and the first 82 nucleotides of the
3'-UTR of chick GAIP. Thus, the 375-bp cDNA sequence 5' to the
hybridizing region is too short to account for the 700-bp difference in
length. The 1.5-kb transcript could be either a GAIP splice variant
with a shorter 3'-UTR or an edited product of the 2.2-bp species. In
both cases, the higher abundance of the 1.5-kb species suggests the
process generates a more stable mRNA.
The open reading frame of chick GAIP encodes a polypeptide of 199 amino
acids, 18 residues shorter than that reported for human GAIP (6). The
RGS and cysteine-rich domains are well conserved. The latter represents
a putative palmitoylation site involved in membrane localization (23).
In addition, all residues known to be covalently modified in human GAIP
are conserved in chick GAIP. Human GAIP is phosphorylated by casein
kinase II at Ser-24 (51) and by Erk1/2 kinase at Ser-151 (52). This
latter modification has functional consequences: when present, it
potentiates the GAP activity of human GAIP (52) and stimulates
autophagy in human colon cancer cells (52). The 2 equivalent positions in the chick GAIP sequence, 2 and 133, are indeed occupied by two
conserved serines, suggesting that chick GAIP is likely to be regulated identically.
In addition to these identities, however, chick GAIP contains a unique
N terminus, containing both a 22-amino acid deletion and a 5-amino acid
insertion. The N terminus has been suggested to play a role in
localization, specificity, and potency of several RGS proteins,
including GAIP. The first 33 residues of RGS4, RGS5, and RGS16 (53,
54), the first 35 residues of RGS8 (47), and the first 66 residues of
RGS2 (55) adopt an amphipathic
-helix conformation that is required
for membrane targeting and biological activity of the proteins.
Deletion mutagenesis identified in the N terminus of RGS4 a domain that
conveys high potency and receptor-selective inhibition of
Gq signaling (44). Furthermore, a GAIP mutant lacking the N
terminus loses its ability to discriminate between Gi- and
Go-mediated pathways in chick DRG neurons (17). These
reports predict that the N-terminal alterations present in chick GAIP
would lead to differences in potency and/or target specificity compared
with mammalian GAIP (6, 23, 34), and our results confirm this prediction.
Chick GAIP Has Unique Target Specificity--
The increases in
G
GTPase activity measured in the presence of chick GAIP
(2-12-fold) are lower than the increases reported for human GAIP
(40-100-fold) (17, 22, 23). Although this could indicate sub-optimal
assay conditions (3), a mathematical model (Appendix) argues against
this possibility. The model is based on the simplifying assumption that
chick GAIP acts exclusively as a GAP. When the model employed increases
in G
o GTPase activity similar to those observed
experimentally, the predictions matched well with the observed
experimental data (see Appendix and Fig. 8).
Results of previously published experiments with human GAIP, carried
out in the Dunlap laboratory under identical experimental conditions
(17), contrast with those reported here for chick GAIP. Human GAIP
eliminates both VD and VI inhibition evoked by GABA application,
whereas chick GAIP is selective for VI inhibition. As both forms of
inhibition require the activation of Go (which has two
splice variants) (28, 56), our results imply that chick GAIP is capable
of discriminating either (i) between two splice variants of the same G
protein subunit or (ii) between two pathways mediated by the identical
G protein subunit. Some specificity of interaction between RGS proteins
and their targets has been achieved in studies in vitro; for
example, in GTPase and yeast two-hybrid assays, human GAIP interacts
well with G
i1, G
i3, and
G
o, but only poorly with G
i2, and not at
all with Gs, Gq, Gz, and
G12/13 (6, 23). In intact systems, however, no RGS protein
has been shown to be able to distinguish among pathways involving
either the same G protein or different isoforms of the same G protein.
These results indicate that, when tested in native cells, chick GAIP
not only has different targets but also has a higher degree of
specificity than does human GAIP. As the only structural differences
between the two GAIP isoforms reside in the N terminus, this region is
likely to confer the unique attributes of chick GAIP.
Conclusions--
We have reported the full-length cloning and
characterization of chick RGS-GAIP, a unique variant with a shorter N
terminus than other previously reported isoforms. The differences in
structure correlate with a higher G protein target specificity in
vitro and in vivo. A mathematical model of GAIP action
(which assumes that GAIP acts exclusively as a GAP) predicts many
features that characterize GAIP effects in intact cells. These findings
suggest that chick GAIP may be helpful for identifying the structural basis of GAIP target specificity.